PCT-1

PCT-1 is a proprietary topical throat spray being developed by PridCor Therapeutics for the treatment of pharyngitis (sore throat) and oral mucositis, particularly in cancer patients undergoing head and neck radiation therapy. The formulation is designed to uniquely adhere to the posterior pharynx, allowing for the consistent delivery of therapeutic medication that persists even after repeated swallows. This adhesive property is intended to provide prolonged relief and address unmet needs in therapeutic throat care by ensuring the medication remains in contact with the affected tissue. While the specific active pharmaceutical ingredient and molecular targets are not publicly disclosed, the product is positioned as a first-of-its-kind advancement in topical throat treatment.